Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up

Detalles Bibliográficos
Autores principales: Wanschitz, Julia V., Kaml, Manuela, Pfausler, Bettina, Helbok, Raimund, Wildner, Sophie, Widmann, Gerlig, Sahanic, Sabina, Deisenhammer, Florian, Löscher, Wolfgang N., Reindl, Markus, Löffler-Ragg, Judith, Beer, Ronny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678580/
https://www.ncbi.nlm.nih.gov/pubmed/33216224
http://dx.doi.org/10.1007/s00415-020-10310-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678580/
https://www.ncbi.nlm.nih.gov/pubmed/33216224
http://dx.doi.org/10.1007/s00415-020-10310-x

Ejemplares similares